백신 투여 기기 시장 규모, 점유율, 성장 분석 : 기기별, 투여 경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Vaccine Delivery Devices Market size was valued at USD 7.33 Billion in 2024 and is poised to grow from USD 7.94 Billion in 2025 to USD 15.02 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The vaccine delivery devices market is experiencing robust growth driven by heightened vaccination initiatives and the demand for effective administration solutions. Key catalysts include the expansion of immunization programs, advancements in needle technologies, and a growing awareness of preventive healthcare. Maintaining vaccine integrity during storage and transport, particularly through cold chain logistics, is a critical focus area. Innovations in delivery devices are designed to ensure proper conditions for vaccines, especially in areas with limited refrigeration access. Developments in temperature-stable formulations and packaging enhance vaccine availability in remote regions. Additionally, the rise of auto-disable syringes, safety needles, and prefilled systems promotes safe and accurate delivery. While North America and Europe lead the market, Asia-Pacific shows significant growth potential, emphasizing the need for innovative and cost-effective solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vaccine Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vaccine Delivery Devices Market Segments Analysis

Global Vaccine Delivery Devices Market is segmented by Type of Device, Route of Administration, End Users and region. Based on Type of Device, the market is segmented into Needle-Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches and Microinjectors. Based on Route of Administration, the market is segmented into Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination and Other Vaccinations. Based on End Users, the market is segmented into Hospitals, Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Vaccine Delivery Devices Market

The increasing prevalence of infectious diseases has significantly amplified the demand for vaccines, particularly in the context of global health initiatives aimed at eradicating preventable illnesses. This growing need for vaccinations underscores the importance of developing efficient and effective vaccine delivery devices, which play a crucial role in facilitating proper immunization. As healthcare providers strive to enhance vaccination rates and improve public health outcomes, the focus on innovative and reliable delivery mechanisms becomes paramount. Consequently, the Vaccine Delivery Devices market is experiencing a surge in demand, driven by the necessity for improved methods of administering vaccines to populations worldwide.

Restraints in the Vaccine Delivery Devices Market

The development and production of innovative vaccine delivery devices often require significant investment in research and development. Such expenses may ultimately be transferred to end-users, such as healthcare providers and patients, which could hinder the broader acceptance and utilization of these devices, especially in areas with limited resources. This financial burden may discourage healthcare facilities from adopting advanced technologies, restricting access to effective immunization solutions and impeding progress in public health initiatives aimed at improving vaccination rates. As a result, the potential benefits of these cutting-edge devices may not be fully realized in certain regions.

Market Trends of the Vaccine Delivery Devices Market

The Vaccine Delivery Devices market is experiencing a notable shift towards innovations in needle-free delivery systems, which are increasingly being embraced to enhance patient comfort and compliance. The rise of alternative delivery methods, including jet injectors, microneedle patches, and nasal sprays, is addressing concerns related to needle aversion while aiming to streamline vaccination processes. These advanced technologies not only minimize the risk of needle-stick injuries but also promise improved vaccine stability and efficacy. As healthcare providers focus on enhancing the overall vaccination experience and increasing accessibility, the demand for these innovative solutions continues to grow, signaling a transformative trend in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis
• Technology Analysis

Global Vaccine Delivery Devices Market Size by Type of Device & CAGR (2026-2033)

• Market Overview
• Needle-Free Injection Systems
• Oral Delivery Systems
• Nasal Delivery Systems
• Jet Injectors
• Microneedle Patches
• Microinjectors

Global Vaccine Delivery Devices Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Intradermal Vaccination
• Intramuscular Vaccination
• Subcutaneous Vaccination
• Other Vaccinations

Global Vaccine Delivery Devices Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Other End Users

Global Vaccine Delivery Devices Market Size & CAGR (2026-2033)

• North America (Type of Device, Route of Administration, End Users)
  • US
  • Canada
• Europe (Type of Device, Route of Administration, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Device, Route of Administration, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Device, Route of Administration, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Device, Route of Administration, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Becton Dickinson & Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inovio Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxas (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCHOTT AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corium International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations